Рет қаралды 138
A team from MIT, Brigham and Women's Hospital and Novo Nordisk develop device for the oral delivery of monoclonal antibodies as well as other therapeutics.
The research was supported by grants from: Novo Nordisk, NIH Grant# EB000244.
Video credit: GT Reel Productions